OBI Pharma Total Liabilities

Latest as of June 2026: NT$495.56 Million TWD ≈ $15.61 Million USD

OBI Pharma total liabilities. Based on the latest financial reports, OBI Pharma (4174) has total liabilities worth NT$495.56 Million TWD (≈ $15.61 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 4174 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of OBI Pharma (2011–2025)

Total liabilities of OBI Pharma from 2011 to 2025. This chart illustrates how OBI Pharma's total liabilities have evolved over time, based on quarterly financial data. Explore 4174 long-term investments to assets to see how much of total assets are deployed in long-term investments.

OBI Pharma Competitors by Total Liabilities

The table below lists competitors of OBI Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
Action S.A. WAR:ACT	Poland	zł377.69 Million
Savior Lifetec TWO:4167	Taiwan	NT$403.30 Million
Young Fast Optoelectronics Co Ltd TW:3622	Taiwan	NT$1.29 Billion
Akwel SA PA:AKW	France	€193.97 Million
Winton Land Ltd AU:WTN	Australia	AU$196.54 Million
Josef Manner & Comp. AG VI:MAN	Austria	€88.81 Million
Urbana Corporation TO:URB-A	Canada	CA$86.26 Million
Limoneira Co NASDAQ:LMNR	USA	$130.12 Million

Liability Composition Analysis (2011–2025)

This chart breaks down OBI Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is OBI Pharma's balance sheet.

Liquidity & Leverage Metrics

OBI Pharma Total Liabilities Ratios Explained

OBI Pharma total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	3.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OBI Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OBI Pharma (2011–2025)

The table below shows the annual total liabilities of OBI Pharma from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$696.13 Million ≈ $21.93 Million	-16.47%
2024-12-31	NT$833.38 Million ≈ $26.26 Million	+28.12%
2023-12-31	NT$650.45 Million ≈ $20.49 Million	+30.73%
2022-12-31	NT$497.57 Million ≈ $15.68 Million	-19.22%
2021-12-31	NT$615.95 Million ≈ $19.41 Million	+22.68%
2020-12-31	NT$502.09 Million ≈ $15.82 Million	+9.35%
2019-12-31	NT$459.14 Million ≈ $14.47 Million	+94.53%
2018-12-31	NT$236.03 Million ≈ $7.44 Million	+82.04%
2017-12-31	NT$129.66 Million ≈ $4.08 Million	-22.51%
2016-12-31	NT$167.32 Million ≈ $5.27 Million	+31.74%
2015-12-31	NT$127.00 Million ≈ $4.00 Million	+187.09%
2014-12-31	NT$44.24 Million ≈ $1.39 Million	+6.71%
2013-12-31	NT$41.46 Million ≈ $1.31 Million	-6.63%
2012-12-31	NT$44.40 Million ≈ $1.40 Million	+211.09%
2011-12-31	NT$14.27 Million ≈ $449.68K	--

About OBI Pharma

TWO:4174 Taiwan Biotechnology

Market Cap

$191.11 Million

NT$6.07 Billion TWD

Market Cap Rank

#16530 Global

#799 in Taiwan

Share Price

NT$46.10

Change (1 day)

-2.54%

52-Week Range

NT$23.25 - NT$59.90

All Time High

NT$743.00